Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Mortality after cancer diagnosis among children with congenital heart disease in Denmark and Sweden

Kampitsi, Christina Evmorfia ; Kenborg, Line ; Mogensen, Hanna ; Broberg, Olof LU ; Glimelius, Ingrid ; Erdmann, Friederike ; Falck Winther, Jeanette ; Feychting, Maria and Tettamanti, Giorgio (2025) In Journal of the National Cancer Institute 117(6). p.1134-1141
Abstract

Background Recent decades have witnessed tangible improvements in childhood cancer survival. However, the prognosis for children with congenital heart disease (CHD), the most prevalent birth defect, remains unclear. Due to improved survival of CHD and childhood cancer, evaluating outcomes within this intersection is important for clinical practice. We aimed to assess mortality post-cancer diagnosis among children with CHD. Methods We conducted a study on the population of Denmark and Sweden, born 1970-2014, with a cancer diagnosis before age 20 in the national cancer registers (end of follow-up 2015; n = 20 665). CHD diagnoses (n = 397) and recorded deaths were retrieved from national health registers. We evaluated the effect of CHD on... (More)

Background Recent decades have witnessed tangible improvements in childhood cancer survival. However, the prognosis for children with congenital heart disease (CHD), the most prevalent birth defect, remains unclear. Due to improved survival of CHD and childhood cancer, evaluating outcomes within this intersection is important for clinical practice. We aimed to assess mortality post-cancer diagnosis among children with CHD. Methods We conducted a study on the population of Denmark and Sweden, born 1970-2014, with a cancer diagnosis before age 20 in the national cancer registers (end of follow-up 2015; n = 20 665). CHD diagnoses (n = 397) and recorded deaths were retrieved from national health registers. We evaluated the effect of CHD on 5-year mortality post-cancer diagnosis fitting Cox proportional hazards regression. Results When excluding children with Down syndrome, children with CHD had a higher 5-year mortality post-cancer diagnosis compared to children without (hazard ratio [HR] 1.48, 95% confidence interval [CI] = 1.18 to 1.86). This was particularly notable in children with lymphoma (HR = 2.17, 95% CI = 1.11 to 4.25) and neuroblastoma (HR = 2.39, 95% CI = 1.11 to 5.15). In more recent decades (post-1990), children with CHD had similar 5-year mortality as their counterparts without, except for children diagnosed with lymphoma, where mortality remained elevated (HR = 3.37, 95% CI = 1.65 to 6.89). Conclusions In this large, register-based cohort study, children with CHD fared worse post-cancer diagnosis - particularly lymphoma and neuroblastoma. While a more positive trend emerged in recent years, lymphoma-related mortality remained disproportionately high among children with CHD, underscoring the need for continued research and interventions to improve outcomes for this vulnerable group.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of the National Cancer Institute
volume
117
issue
6
pages
8 pages
publisher
Oxford University Press
external identifiers
  • pmid:39821282
  • scopus:105008252015
ISSN
0027-8874
DOI
10.1093/jnci/djaf010
language
English
LU publication?
yes
additional info
Publisher Copyright: © 2025 The Author(s). Published by Oxford University Press.
id
6f3b0c13-aa43-4aa6-88f9-34626cb14af6
date added to LUP
2025-12-16 11:22:40
date last changed
2025-12-17 03:00:19
@article{6f3b0c13-aa43-4aa6-88f9-34626cb14af6,
  abstract     = {{<p>Background Recent decades have witnessed tangible improvements in childhood cancer survival. However, the prognosis for children with congenital heart disease (CHD), the most prevalent birth defect, remains unclear. Due to improved survival of CHD and childhood cancer, evaluating outcomes within this intersection is important for clinical practice. We aimed to assess mortality post-cancer diagnosis among children with CHD. Methods We conducted a study on the population of Denmark and Sweden, born 1970-2014, with a cancer diagnosis before age 20 in the national cancer registers (end of follow-up 2015; n = 20 665). CHD diagnoses (n = 397) and recorded deaths were retrieved from national health registers. We evaluated the effect of CHD on 5-year mortality post-cancer diagnosis fitting Cox proportional hazards regression. Results When excluding children with Down syndrome, children with CHD had a higher 5-year mortality post-cancer diagnosis compared to children without (hazard ratio [HR] 1.48, 95% confidence interval [CI] = 1.18 to 1.86). This was particularly notable in children with lymphoma (HR = 2.17, 95% CI = 1.11 to 4.25) and neuroblastoma (HR = 2.39, 95% CI = 1.11 to 5.15). In more recent decades (post-1990), children with CHD had similar 5-year mortality as their counterparts without, except for children diagnosed with lymphoma, where mortality remained elevated (HR = 3.37, 95% CI = 1.65 to 6.89). Conclusions In this large, register-based cohort study, children with CHD fared worse post-cancer diagnosis - particularly lymphoma and neuroblastoma. While a more positive trend emerged in recent years, lymphoma-related mortality remained disproportionately high among children with CHD, underscoring the need for continued research and interventions to improve outcomes for this vulnerable group.</p>}},
  author       = {{Kampitsi, Christina Evmorfia and Kenborg, Line and Mogensen, Hanna and Broberg, Olof and Glimelius, Ingrid and Erdmann, Friederike and Falck Winther, Jeanette and Feychting, Maria and Tettamanti, Giorgio}},
  issn         = {{0027-8874}},
  language     = {{eng}},
  month        = {{06}},
  number       = {{6}},
  pages        = {{1134--1141}},
  publisher    = {{Oxford University Press}},
  series       = {{Journal of the National Cancer Institute}},
  title        = {{Mortality after cancer diagnosis among children with congenital heart disease in Denmark and Sweden}},
  url          = {{http://dx.doi.org/10.1093/jnci/djaf010}},
  doi          = {{10.1093/jnci/djaf010}},
  volume       = {{117}},
  year         = {{2025}},
}